Human medicines European public assessment report (EPAR): Zoledronic acid Teva Pharma, zoledronic acid, Osteoporosis,Osteitis Deformans,Osteoporosis, Postmenopausal, Date of authorisation: 15/08/2012, Revision: 11, Status: Withdrawn - Withdrawal Notice | RetractBase